tailieunhanh - Báo cáo y học: " Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care | Fabião et al. BMC Psychiatry 2010 10 34 http 1471-244X 10 34 BMC Psychiatry RESEARCH ARTICLE Open Access Assessing medically unexplained symptoms evaluation of a shortened version of the SOMS for use in primary care Cristina Fabiao 1 MC Silva2 António Barbosa3 Manuela Fleming4 and Winfried Rief5 Abstract Background To investigate the validity and stability of a Portuguese version for the Screening for Somatoform Symptoms-2 SOMS-2 in primary care PC settings. Methods An adapted version of the SOMS-2 was filled in by persons attending a PC unit. All medically unexplained symptoms were further ascertained in a clinical interview and by contacting the patient s physicians and examining medical records attaining a final clinical symptom evaluation FCSE . An interview yielded the diagnosis of Clinical Somatization CS and the diagnosis of current depressive and anxiety disorders. Results From the eligible subjects 167 agreed to participate and of them were diagnosed with somatization. The correlation between the number of self-reported and FCSE symptoms was . After excluding symptoms with low frequency low discriminative power and not correlated with the overall scale 29 were retained in the final version. A cut-off of 4 symptoms gave a sensitivity of and a specificity of on the FCSE and and at selfreport. Stability in the number of symptoms after 6 months was good k . Conclusions The 29 symptoms version of the SOMS-2 with a cut-off of 4 showed a high specificity and sensitivity being reliable as a referral tool for further specialized diagnosis. Background As the DSM III-R and IV Somatization Disorder was extremely rare in PC settings and many patients presented medically unexplained symptoms MUS the need for an abridged somatization definition became evident. The Somatic Symptom Index SSI 6 4 1 and the Multisomatoform Disorder MSD 2 were proposed and validated. Several studies reported high prevalence estimates for